Jamie L. Reynoso - Jan 31, 2022 Form 4/A - Amendment Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
CEO of Medicare Advantage
Signature
/s/ Joseph R. Martin as attorney-in-fact for Jamie L. Reynoso
Stock symbol
CLOV
Transactions as of
Jan 31, 2022
Transactions value $
-$3,305
Form type
4/A - Amendment
Date filed
4/26/2023, 09:56 PM
Date Of Original Report
Feb 2, 2022
Previous filing
Apr 26, 2023
Next filing
Mar 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Tax liability -$3.3K -1.28K -0.54% $2.58 235K Jan 31, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A, amends the original Form 4, filed on February 2, 2022, solely to report the number of shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on January 31, 2022, of 1/3rd of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The RSUs vest in equal installments on January 31, 2022, January 1, 2023 and January 1, 2024.
F2 The original Form 4 inadvertently omitted the 1,281 shares that were withheld in connection with the January 31, 2022 vesting event.